Blog

Surgical Resection Improves Survival in T1 Esophageal Cancer

For T1 superficial esophageal cancer patients with non-curative endoscopic resection, additional surgical resection significantly enhances survival outcomes.

  • Overall survival rates at 5 years: 91.4% for surgical resection vs. 78.2% for non-surgical.
  • Recurrence-free survival rates at 5 years: 83.6% for surgical vs. 73.8% for non-surgical.

Surgical intervention is critical for improving long-term survival, especially in high-risk patients.

  • Disease-specific survival at 5 years: 97.8% for surgical vs. 91.1% for non-surgical.

Journal Article by Chen Y, Cao L (…) Deng K et 3 al. in Int J Surg

Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.

read the whole article in Int J Surg

open it in PubMed

Effective GERD Solution: Long-Term Gains from ARMS-L

Ligation-assisted antireflux mucosectomy (ARMS-L) shows promising long-term outcomes for patients with proton pump inhibitor (PPI)-dependent GERD.

  • 70.3% of patients achieved over 50% improvement in GERD symptoms after an average of 48 months.
  • Significant increases in lower esophageal sphincter pressure were noted: resting pressure rose from 6.3 to 6.6 mmHg, and residual pressure increased from 5.9 to 7.2 mmHg.
  • 70.9% of patients discontinued PPIs, indicating a potential shift in long-term management for GERD.

Prioritize ARMS-L in suitable patients to enhance symptom relief and reduce PPI reliance.

Journal Article by Zhu Y, Liu B (…) Liu X et 8 al. in United European Gastroenterol J

© 2025 The Author(s). United European Gastroenterology Journal published by Wiley Periodicals LLC on behalf of United European Gastroenterology.

read the whole article in United European Gastroenterol J

open it in PubMed

Robotic Assistance Enhances Endoscopic Submucosal Dissection

A new robotic system improves endoscopic submucosal dissection (ESD) efficiency and safety for gastrointestinal tumors.

  • En bloc resection rates are similar: 98.84% for the robotic group vs. 98.13% for conventional methods.
  • Robotic assistance cut dissection time significantly (p = 0.00435) and improved submucosal visualization while reducing muscular injury and operator workload.

This system acts as a “third hand,” enhancing surgical precision and workflow without compromising outcomes.

Randomized Controlled Trial by Fan K, Lv ML (…) Yang J et 6 al. in J Robot Surg

© 2025. The Author(s), under exclusive licence to Springer-Verlag London Ltd., part of Springer Nature.

read the whole article in J Robot Surg

open it in PubMed

Older Adults at Higher Risk Post-Hollow Viscus Injury

Older adults (65+) decompensate rapidly after blunt hollow viscus injuries, affecting surgical outcomes.

  • Mortality odds for older adults undergoing surgery are eight times higher than for younger adults.
  • Older adults wait nearly double the time to surgery compared to younger patients.

Delays over one hour from admission to surgery significantly increase mortality risk.

  • After 48 hours, older adults face a 13-point higher probability of death (16.20% vs. 3.28%).

Timely diagnosis and surgical intervention are critical to improving outcomes in elderly trauma patients.

Journal Article by Larson NJ, Dries DJ (…) Rogers FB et 4 al. in J Surg Res

Copyright © 2025 Elsevier Inc. All rights reserved.

read the whole article in J Surg Res

open it in PubMed

Optimal Lymphadenectomy Balances Immunotherapy in Gastric Cancer

A new study shows that the extent of lymph node dissection impacts immunotherapy efficacy in recurrent gastric cancer, emphasizing precise surgical strategies.

  • Patients with moderate lymph node dissection (16-30 nodes) achieved the best progression-free survival (8.0 months) compared to insufficient (≤15 nodes, 6.0 months) and excessive (>30 nodes, 7.0 months) resections.
  • Overall survival was highest in the moderate dissection group, with a median of 18.0 months versus 14.0 months for insufficient and 13.0 months for excessive dissections.

Surgeons should aim for balanced lymphadenectomy to enhance patient outcomes while maintaining antitumor immunity.

  • Multivariate analysis identified lymph node count as the sole independent predictor of survival outcomes.

Journal Article by Zhu D, Fang Z (…) Cheng X et 6 al. in Eur J Surg Oncol

Copyright © 2025 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

read the whole article in Eur J Surg Oncol

open it in PubMed

Sequential Strategy Improves Survival in High-Risk Liver Metastases

A sequential approach combining neoadjuvant and adjuvant chemotherapy with surgery markedly boosts survival for high-risk colorectal liver metastasis patients.

  • Patients receiving neoadjuvant chemotherapy had a median progression-free survival of 1.1 years versus 0.6 years for surgery-first patients (p<0.001).
  • Overall survival was better in the neoadjuvant group: 5.2 years compared to 4.3 years (p=0.044).

Completing the entire treatment sequence correlates with the best outcomes.

  • Matched analysis confirmed these findings, indicating a clear benefit to neoadjuvant therapy before surgery.

Journal Article by Kobayashi K, Ono Y (…) Takahashi Y et 8 al. in Surg Today

© 2025. The Author(s) under exclusive licence to Springer Nature Singapore Pte Ltd.

read the whole article in Surg Today

open it in PubMed

Improved Survival After Liver Resection for HCC

Long-term survival rates for hepatocellular carcinoma patients significantly improved following liver resection over 20 years.

  • 5-year overall survival rates increased from 68.1% to 90.5% across three time periods (1996-2017).
  • Short-term outcomes enhanced, with 90-day mortality dropping to just 0.3% and major complications at 5.0%.

These advancements result from better surgical techniques and patient selection, allowing for safer and more effective surgeries for older patients and those with diverse HCC types.

  • Increased identification of non-B and non-C HCC cases and declining cirrhosis rates contribute to this trend.

Journal Article by Kim NR, Choi GH (…) Choi JS et 2 al. in Yonsei Med J

© Copyright: Yonsei University College of Medicine 2025.

read the whole article in Yonsei Med J

open it in PubMed

Successful Robotic Colorectal Surgeries with da Vinci Xi

Transitioning to the da Vinci Xi robotic platform for colorectal cancer surgery shows a significant improvement in outcomes.

  • 100% of colonic resections achieved a lymph node yield of 12 or more, surpassing the national average of 88.1%.
  • Only 3% conversion to open surgery, with a 1% anastomotic leak rate.

Robotic procedures also led to shorter hospital stays—just 7.1% had stays over 9 days versus 29% nationally.

  • Learning curves demonstrate surgeons with previous robotic experience gained proficiency faster, highlighting the need for structured training programs.

Journal Article by Massias S, Vadhwana B (…) Patel V et 5 al. in J Robot Surg

© 2025. The Author(s).

read the whole article in J Robot Surg

open it in PubMed

Postoperative ctDNA Predicts Recurrence in Rectal Cancer

Postoperative circulating tumor DNA (ctDNA) testing could transform management for rectal cancer patients undergoing surgery.

  • 14.2% of patients were ctDNA-positive shortly post-surgery, with a significantly higher recurrence risk (HR: 9.96, p<0.0001).
  • ctDNA-positive patients benefited from adjuvant chemotherapy (HR: 0.28, p=0.031), while ctDNA-negative patients did not (HR: 0.59, p=0.211).

Monitoring ctDNA can guide treatment decisions, optimizing outcomes for high-risk patients and avoiding unnecessary therapies for low-risk individuals.

  • Recurrence risk escalated for patients whose ctDNA status worsened from negative to positive (HR: 8.22, p=0.0055) and for those consistently positive (HR: 45.48, p<0.0001).

Journal Article by Ando K, Hamabe A (…) Oki E et 25 al. in Ann Surg

Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc.

read the whole article in Ann Surg

open it in PubMed

Endoscopic gastroenterostomy outperforms surgical method in obstruction

A randomized trial shows that endoscopic ultrasound-guided gastroenterostomy (EUS-GE) significantly improves outcomes for patients with malignant gastric outlet obstruction over traditional surgical gastrojejunostomy (SGJ).

  • Primary endpoint success occurred in only 7.9% of EUS-GE patients compared to 38.9% for SGJ (risk difference -31.0%).
  • Patients on EUS-GE advanced to a solid diet in a median of 2 days vs. 5 days for SGJ, with shorter hospital stays (3 days vs. 9 days).

EUS-GE also resulted in improved quality of life and lower treatment costs (approximately $33,934 vs. $51,437).

  • These findings suggest that EUS-GE could be the preferred approach for palliation in this patient population, enhancing recovery and reducing healthcare costs.

Journal Article by Bang JY, Puri R (…) Varadarajulu S et 20 al. in Gut

© Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.

read the whole article in Gut

open it in PubMed